Keytruda (pembrolizumab)
Multiple Cancer Types
CommercialActive
Key Facts
About Merck
Merck & Co., Inc. is a leading research-intensive biopharmaceutical company founded in 1891 and headquartered in Rahway, New Jersey. With a market valuation of approximately $282 billion, the company has built a legacy of breakthrough medicines and vaccines, including the blockbuster cancer immunotherapy Keytruda and vaccines like Gardasil. Merck operates globally, reaching 92% of the world's countries with its products and serving over 450 million people with medicines and vaccines in 2024.
View full company profileTherapeutic Areas
Other Multiple Cancer Types Drugs
| Drug | Company | Phase |
|---|---|---|
| BNT327 | BioNTech | Phase 2/3 |
| Opdivo (nivolumab) | Bristol Myers Squibb | Commercial |
| Camrelizumab (SHR-1210) | Jiangsu Hengrui Medicine | Approved |
| LENVIMA (lenvatinib) | Eisai | Commercial |